Video Experimental Relacionado
Updated: Sep 10, 2025
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
Mortalidad no relacionada con el cáncer en ensayos clínicos aleatorizados: un metanálisis
Jiayao Lei1,2,3, Yunyang Deng1, Mark Clements1
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
JAMA network open
|August 25, 2025
Resumen
La detección del cáncer no aumenta significativamente las muertes no relacionadas con el cáncer. Evaluar por separado la mortalidad dirigida y la no dirigida es crucial para comprender completamente los impactos del cribado.
Área de la Ciencia:
- En el campo de la oncología
- Salud pública
- Estadísticas biológicas
Sus antecedentes:
- La detección del cáncer es vital para reducir la mortalidad por cáncer, pero conlleva riesgos como el sobrediagnóstico.
- La evaluación del impacto del cribado únicamente por la mortalidad por cualquier causa es insuficiente debido a su insensibilidad a los beneficios y daños.
- La comprensión de la mortalidad no relacionada con el cáncer (fuera del objetivo) es esencial para una evaluación integral de la detección del cáncer.
Objetivo del estudio:
- Evaluar la asociación entre el cribado del cáncer y la mortalidad fuera del objetivo.
- Comparar las tasas de mortalidad entre los individuos examinados y no examinados utilizando ensayos clínicos aleatorios (ECA).
Principales métodos:
- Revisión sistemática y metanálisis de los ECA existentes sobre el cribado del cáncer.
- Se incluyeron ECA con datos sobre la mortalidad por cáncer por todas las causas y por cáncer dirigido.
- Se analizó la mortalidad fuera del objetivo utilizando ratios de tasa (RR) e intervalos de confianza (IC) del 95% mediante un modelo de efectos fijos.
Principales resultados:
- Análisis de 17 ECA en los que participaron más de 1,3 millones de personas.
- Los exámenes de detección de cáncer no mostraron un aumento significativo de la mortalidad fuera del objetivo (RR, 1, 00; IC del 95%, 1, 00-1, 01).
- El aumento general de la mortalidad fuera del objetivo fue mínimo (0,2%), sin que se observara una heterogeneidad significativa.
Conclusiones:
- La detección del cáncer no está asociada con un aumento sustancial de la mortalidad no relacionada con el cáncer.
- Los hallazgos ponen de relieve la importancia de analizar de forma independiente la mortalidad dirigida y la no dirigida.
- Confiar únicamente en la mortalidad por todas las causas puede oscurecer el verdadero impacto de las intervenciones de detección de cáncer.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:12Hazard Ratio
243
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
243
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
01:16Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:20Comparing the Survival Analysis of Two or More Groups
285
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
285